Pyrimidines as PLK inhibitors

US7521457B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Heinz Stadtmueller · Wien, AT
• Harald Engelhardt · Ebreichsdorf, AT
• Martin Steegmaier · Wien, AT
• Anke Baum · Alland, AT
• Ulrich Guertler · Wien, AT
• Andreas Schoop · Overath, DE
• Jens Juergen Quant · Guntramsdorf, AT
• Flavio Solca · Wien, AT
• Rudolf Hauptmann · Ebreichsdorf, AT
• Ulrich Reiser · Wien, AT
• Stephan Karl Zahn · Wien, AT
• Lars HERFURTH · Wien, AT

Key dates

• Filing date: Aug 17, 2005
• Grant date: Apr 21, 2009
• Expiry date: Aug 17, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention encompasses compounds of general formula (1),wherein